Unraveling the natural history of presymptomatic cystinuria

Purpose of review Servais et al. recently published clinical practice recommendations for the care of cystinuria patients. However, these guidelines were largely based on retrospective data from adults and children presenting with stones. Significant questions remain about the natural history of cystinuria in presymptomatic children. Recent findings We review the natural history of cystinuria in presymptomatic children followed from birth. In total, 130 pediatric patients were assigned putative genotypes based on parental urinary phenotype: type A/A (N = 23), B/B (N = 6), and B/N (N = 101). Stones were identified in 12/130 (4% of A/A, 17% of B/B, and 1% of B/N patients). Type B/B patients had lower cystine excretion than type A/A patients. Although urine cystine/creatinine fell with age, urine cystine/l rose progressively in parallel with the risk of nephrolithiasis. Each new stone was preceded by 6–12 months of urine specific gravity of more than 1.020. However, average urine specific gravity and pH were not different in stone formers vs. nonstone formers, suggesting that intrinsic stone inhibitors or other unknown factors may be the strongest determinants of individual risk. Summary The current study reviews the clinical evolution of cystinuria in a cohort of children identified by newborn screening, who were categorized by urinary phenotype and followed from birth.

[1]  José María Egea-Mellado,et al.  Phenotypic characterization of a pediatric cohort with cystinuria and usefulness of newborn screening , 2022, Pediatric Nephrology.

[2]  M. Bultitude,et al.  Cystinuria: clinical practice recommendation. , 2020, Kidney international.

[3]  M. Palacín,et al.  Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1 , 2016, Proceedings of the National Academy of Sciences.

[4]  M. Daudon,et al.  CKD and Its Risk Factors among Patients with Cystinuria. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[5]  D. Goldfarb,et al.  Pathophysiology and treatment of cystinuria , 2010, Nature Reviews Nephrology.

[6]  R. Rozen,et al.  Transient neonatal cystinuria. , 2005, Kidney international.

[7]  M. Palacín,et al.  New insights into cystinuria: 40 new mutations, genotype–phenotype correlation, and digenic inheritance causing partial phenotype , 2005, Journal of Medical Genetics.

[8]  R. Rozen,et al.  Studies of urinary cystine precipitation in vitro: ontogeny of cystine nephrolithiasis and identification of meso-2,3-dimercaptosuccinic acid as a potential therapy for cystinuria. , 2003, Molecular genetics and metabolism.

[9]  R. Rozen,et al.  SLC7A9 mutations in all three cystinuria subtypes. , 2002, Kidney international.

[10]  B. Burt,et al.  Fluid consumption related to climate among children in the United States. , 2001, Journal of public health dentistry.

[11]  X. Estivill,et al.  Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT , 1999, Nature Genetics.

[12]  R. Rozen,et al.  Cystinuria subtype and the risk of nephrolithiasis. , 1998, Kidney international.

[13]  X. Estivill,et al.  Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine , 1994, Nature Genetics.